Evidence map›Paper›PMID 27942535›Full record

ArticleNuclear receptor research2016

Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity.

Harmit S Ranhotra, Kyle L Flannigan, Martina Brave, Subhajit Mukherjee, Dana J Lukin, Simon A Hirota, Sridhar Mani

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Nuclear receptor research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06272240 (Study of the Role of the Tumor Microenvironment in Ovarian Cancer), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06272240 recruitingnot on this mapstarted 2024, after this paper: background citation

Study of the Role of the Tumor Microenvironment in Ovarian Cancer

Typeobservational_patient_registrySponsorUniversity of UdineRan2024 to 2027Enrolled50ConditionsOvarian Cancer Stage III, Ovarian Cancer Stage IVArmsOvarian Cancer Organoids
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Integrating the gut microbiome and pharmacology.Science translational medicine · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  17. Article
  18. Ammonia generation by tryptophan synthase drives a key genetic difference between genital and ocularProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Harmit S RanhotraDepartments of Medicine and Genetics, The Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.
Kyle L FlanniganDepartments of Physiology and Pharmacology, University of Calgary, 3330 Hospital Dr. NW, Health Sciences Room 1802, Calgary, Alberta T2N4N1.
Martina BraveDepartments of Medicine and Genetics, The Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.
Subhajit MukherjeeDepartments of Medicine and Genetics, The Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.
Dana J LukinDepartments of Medicine and Genetics, The Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.
Simon A HirotaDepartments of Physiology and Pharmacology, University of Calgary, 3330 Hospital Dr. NW, Health Sciences Room 1802, Calgary, Alberta T2N4N1.
Sridhar ManiDepartments of Medicine and Genetics, The Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.
Albert Einstein College of Medicine · USUniversity of Calgary · CA

Funding

RESEARCH TRAININGP30DK026687 · NIDDK · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI Anthony W Ferrante, DYMPNA GALLAGHER · 1986 to 2026
$33.0M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Chemical Modulation of Orphan Nuclear Receptor FunctionR01CA127231 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI MANI, SRIDHAR · 2009 to 2014
$1.6M
Development of Novel Drugs to Alleviate CPT-11 ToxicityR01CA161879 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI MANI, SRIDHAR, REDINBO, MATTHEW R · 2012 to 2016
$1.6M
NCATS NIH HHS UL1 TR001073NCI NIH HHS R01 CA127231NCI NIH HHS R01 CA161879NIDDK NIH HHS P30 DK026687
6 · The paper itself

Abstract

The molecular basis for the regulation of the intestinal barrier is a very fertile research area. A growing body of knowledge supports the targeting of various components of intestinal barrier function as means to treat a variety of diseases, including the inflammatory bowel diseases. Herein, we will summarize the current state of knowledge of

Indexed as

barrier functionintestinal innate immunitymicrobial metabolitesOrphan nuclear receptorsxenobiotics

Identifiers

PMID27942535
PMCPMC5145265
OpenAlexW2467332937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.